ENTRY       D00975                      Drug
NAME        Dexamethasone sodium phosphate (JAN/USP);
            Dalalone (TN);
            Maxidex (TN)
PRODUCT
  GENERIC   DEXAMETHASONE SODIUM PHOSPHATE (A-S Medication Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (A-S Medication Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (A-S Medication Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Advanced Rx Pharmacy of Tennessee)
            DEXAMETHASONE SODIUM PHOSPHATE (Amneal Pharmaceuticals LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Amneal Pharmaceuticals LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Asclemed USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Asclemed USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Asclemed USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Bausch & Lomb Incorporated)
            DEXAMETHASONE SODIUM PHOSPHATE (Cardinal Health 107)
            DEXAMETHASONE SODIUM PHOSPHATE (Cardinal Health 107)
            DEXAMETHASONE SODIUM PHOSPHATE (Civica)
            DEXAMETHASONE SODIUM PHOSPHATE (Eugia US LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Eugia US LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Eugia US LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Fresenius Kabi USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Fresenius Kabi USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Fresenius Kabi USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Fresenius Kabi USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Fresenius Kabi USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Fresenius Kabi USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Fresenius Kabi USA)
            DEXAMETHASONE SODIUM PHOSPHATE (General Injectables and Vaccines)
            DEXAMETHASONE SODIUM PHOSPHATE (General Injectables and Vaccines)
            DEXAMETHASONE SODIUM PHOSPHATE (Gland Pharma Limited)
            DEXAMETHASONE SODIUM PHOSPHATE (HF Acquisition Co LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (HF Acquisition Co LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (HF Acquisition Co LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (HF Acquisition Co LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (HF Acquisition Co LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (HF Acquisition Co LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Henry Schein)
            DEXAMETHASONE SODIUM PHOSPHATE (Henry Schein)
            DEXAMETHASONE SODIUM PHOSPHATE (Henry Schein)
            DEXAMETHASONE SODIUM PHOSPHATE (Hikma Pharmaceuticals USA)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Medical Purchasing Solutions)
            DEXAMETHASONE SODIUM PHOSPHATE (Mylan Institutional LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Mylan Institutional LLC)
            DEXAMETHASONE SODIUM PHOSPHATE (Phlow Corporation)
            DEXAMETHASONE SODIUM PHOSPHATE (REMEDYREPACK)
            DEXAMETHASONE SODIUM PHOSPHATE (REMEDYREPACK)
            DEXAMETHASONE SODIUM PHOSPHATE (REMEDYREPACK)
            DEXAMETHASONE SODIUM PHOSPHATE (REMEDYREPACK)
            DEXAMETHASONE SODIUM PHOSPHATE (REMEDYREPACK)
            DEXAMETHASONE SODIUM PHOSPHATE (REMEDYREPACK)
            DEXAMETHASONE SODIUM PHOSPHATE (REMEDYREPACK)
            DEXAMETHASONE SODIUM PHOSPHATE (Somerset Therapeutics)
            DEXAMETHASONE SODIUM PHOSPHATE (Somerset Therapeutics)
            DEXAMETHASONE SODIUM PHOSPHATE (Somerset Therapeutics)
FORMULA     C22H28FO8P. 2Na
EXACT_MASS  516.1301
MOL_WEIGHT  516.4046
CLASS       Anti-inflammatory
             DG01955  Corticosteroid
              DG02068  Glucocorticoid
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
REMARK      Same as: C08175
            Therapeutic category: 1315 1329 2454
            ATC code: A01AC02 C05AA09 D07AB19 D07XB05 D10AA03 H02AB02 R01AD03 S01BA01 S01CB01 S02BA06 S03BA01
            Chemical structure group: DG00011
            Product (DG00011): D00292<JP/US> D00975<JP/US> D01510<JP> D01615<JP> D01632<JP> D01948<JP> D07073<JP>
EFFICACY    Anti-inflammatory, Glucocorticoid receptor agonist
  DISEASE   Primary or secondary adrenocortical insufficiency [DS:H01598]
            Congenital adrenal hyperplasia [DS:H00216]
            Rheumatoid arthritis [DS:H00630]
            Juvenile rheumatoid arthritis [DS:H01672]
            Acute gouty arthritis [DS:H01532]
            Psoriatic arthritis [DS:H01507]
            Ankylosing spondylitis [DS:H01674]
            Systemic lupus erythematosus [DS:H00080]
            Pemphigus [DS:H01648]
            Severe erythema multiforme [DS:H01695]
            Stevens-Johnson syndrome [DS:H01694]
            Seborrheic dermatitis [DS:H01652]
            Psoriasis [DS:H01656]
            Mycosis fungoides [DS:H01463]
            Bronchial asthma [DS:H00079]
            Contact dermatitis [DS:H01357]
            Atopic dermatitis [DS:H01358]
            Seasonal or perennial allergic rhinitis [DS:H01360]
            Herpes zoster ophthalmicus [DS:H00366]
            Optic neuritis [DS:H01717]
            Ulcerative colitis [DS:H01466]
            Pulmonary tuberculosis [DS:H00342]
            Acquired (autoimmune) hemolytic anemia [DS:H01585]
            Nephrotic syndrome [DS:H01657]
TARGET      NR3C1 (GR) [HSA:2908] [KO:K05771]
  PATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION CYP induction: CYP3A4 [HSA:1576]
STR_MAP     map07225  Glucocorticoid and mineralocorticoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AC Corticosteroids for local oral treatment
                 A01AC02 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
             C CARDIOVASCULAR SYSTEM
              C05 VASOPROTECTIVES
               C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
                C05AA Corticosteroids
                 C05AA09 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
             D DERMATOLOGICALS
              D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
               D07A CORTICOSTEROIDS, PLAIN
                D07AB Corticosteroids, moderately potent (group II)
                 D07AB19 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
               D07X CORTICOSTEROIDS, OTHER COMBINATIONS
                D07XB Corticosteroids, moderately potent, other combinations
                 D07XB05 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
              D10 ANTI-ACNE PREPARATIONS
               D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
                D10AA Corticosteroids, combinations for treatment of acne
                 D10AA03 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H02 CORTICOSTEROIDS FOR SYSTEMIC USE
               H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
                H02AB Glucocorticoids
                 H02AB02 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
             R RESPIRATORY SYSTEM
              R01 NASAL PREPARATIONS
               R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
                R01AD Corticosteroids
                 R01AD03 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01B ANTIINFLAMMATORY AGENTS
                S01BA Corticosteroids, plain
                 S01BA01 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
               S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
                S01CB Corticosteroids/antiinfectives/mydriatics in combination
                 S01CB01 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
              S02 OTOLOGICALS
               S02B CORTICOSTEROIDS
                S02BA Corticosteroids
                 S02BA06 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
              S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
               S03B CORTICOSTEROIDS
                S03BA Corticosteroids
                 S03BA01 Dexamethasone
                  D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
              Dexamethasone
               D00975  Dexamethasone sodium phosphate (JAN/USP)
             Inflammatory Bowel Disease Agents
              Glucocorticoids
               Dexamethasone
                D00975  Dexamethasone sodium phosphate (JAN/USP)
             Ophthalmic Agents
              Ophthalmic Anti-inflammatories
               Glucocorticoids, Ophthalmic
                Dexamethasone
                 D00975  Dexamethasone sodium phosphate (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1315  Ophthalmic cortisones
                 D00975  Dexamethasone sodium phosphate (JAN/USP)
               132  Otic and nasal agents
                1329  Others
                 D00975  Dexamethasone sodium phosphate (JAN/USP)
             2  Agents affecting individual organs
              24  Hormones
               245  Adrenal hormone preparations
                2454  Fluorinated adrenocorticotropic hormones
                 D00975  Dexamethasone sodium phosphate (JAN/USP)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00011  Dexamethasone
                 D00975  Dexamethasone sodium phosphate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00975  Dexamethasone sodium phosphate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00011  Dexamethasone
                 D00975  Dexamethasone sodium phosphate
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00011  Dexamethasone
                 D00975  Dexamethasone sodium phosphate
            Drug classes [BR:br08332]
             Anti-inflammatory
              DG01955  Corticosteroid
               D00975  Dexamethasone sodium phosphate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00975  Dexamethasone sodium phosphate
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                NR3C1 (GR)
                 D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00975
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00011  Dexamethasone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00011  Dexamethasone
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00011  Dexamethasone
DBLINKS     CAS: 2392-39-4
            PubChem: 7848038
            ChEBI: 4462
            LigandBox: D00975
            NIKKAJI: J7.881F
ATOM        34
            1   C1y C    20.5509  -18.6771
            2   C1y C    19.3622  -19.3588
            3   C1z C    20.5626  -17.2961
            4   C1x C    22.9399  -18.7004
            5   C1z C    18.1794  -18.6655
            6   C1x C    19.3622  -20.7281
            7   C1z C    21.7686  -16.6144
            8   C1x C    19.3855  -16.6144
            9   C1a C    20.5567  -15.9269
            10  C1y C    22.9514  -17.3253
            11  C1z C    16.9908  -19.3471
            12  C1y C    18.1910  -17.2961
            13  X   F    18.1677  -20.0289
            14  C1x C    18.1677  -21.4098
            15  C5a C    21.7745  -15.2451
            16  O1a O    23.0913  -16.2589
            17  C1a C    24.2741  -17.1681
            18  C2y C    16.9849  -20.7222
            19  C2x C    15.8021  -18.6596
            20  C1a C    16.9791  -17.9662
            21  O1a O    17.0025  -16.6028
            22  C1b C    22.9573  -14.5575
            23  O5a O    20.5743  -14.5575
            24  C2x C    15.8021  -21.4040
            25  C2x C    14.6135  -19.3471
            26  O2b O    24.1401  -15.2334
            27  C5x C    14.6135  -20.7222
            28  P1b P    25.2763  -14.4585
            29  O5x O    13.4190  -21.3981
            30  O1c O    26.4534  -15.1461
            31  O1c O    26.4068  -13.6836 #-
            32  O1c O    24.5014  -13.3223 #-
            33  Z   Na   28.9880  -14.9538 #+
            34  Z   Na   28.9181  -18.1935 #+
BOND        35
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     3   9 1 #Up
            9     4  10 1
            10    5  11 1
            11    5  12 1
            12    5  13 1 #Down
            13    6  14 1
            14    7  15 1 #Up
            15    7  16 1 #Down
            16   10  17 1 #Down
            17   11  18 1
            18   11  19 1
            19   11  20 1 #Up
            20   12  21 1 #Up
            21   15  22 1
            22   15  23 2
            23   18  24 2
            24   19  25 2
            25   22  26 1
            26   24  27 1
            27   26  28 1
            28   27  29 2
            29   28  30 2
            30   28  31 1
            31   28  32 1
            32    7  10 1
            33    8  12 1
            34   14  18 1
            35   25  27 1
///
